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Homozygosity Mapping Reveals
Null Mutations in FAM161A as a Cause of
Autosomal-Recessive Retinitis Pigmentosa
Dikla Bandah-Rozenfeld,1 Liliana Mizrahi-Meissonnier,1 Chen Farhy,2 Alexey Obolensky,1
Itay Chowers,1 Jacob Pe’er,1 Saul Merin,3 Tamar Ben-Yosef,4 Ruth Ashery-Padan,2 Eyal Banin,1,*
and Dror Sharon1,*
Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal degenerations caused by mutations in at least 45 genes. Using
homozygosity mapping, we identified a ~4 Mb homozygous region on chromosome 2p15 in patients with autosomal-recessive RP
(arRP). This region partially overlaps with RP28, a previously identified arRP locus. Sequence analysis of 12 candidate genes revealed
three null mutations in FAM161A in 20 families. RT-PCR analysis in 21 human tissues revealed high levels of FAM161A expression in
the retina and lower levels in the brain and testis. In the human retina, we identified two alternatively spliced transcripts with an intact
open reading frame, themajor one lacking a highly conserved exon. Duringmouse embryonic development, low levels of Fam161a tran-
scripts were detected throughout the optic cup. After birth, Fam161a expression was elevated and confined to the photoreceptor layer.
FAM161A encodes a protein of unknown function that is moderately conserved in mammals. Clinical manifestations of patients with
FAM161A mutations varied but were largely within the spectrum associated with arRP. On funduscopy, pallor of the optic discs and
attenuation of blood vessels were common, but bone-spicule-like pigmentation was oftenmild or lacking. Most patients had nonrecord-
able electroretinographic responses and constriction of visual fields upon diagnosis. Our data suggest a pivotal role for FAM161A in
photoreceptors and reveal that FAM161A loss-of-function mutations are a major cause of arRP, accounting for ~12% of arRP families
in our cohort of patients from Israel and the Palestinian territories.Retinitis pigmentosa (RP [MIM 268000]) is the most
common inherited retinal degeneration, with an estimated
worldwide prevalence of 1:4000.1–3 The disease is highly
heterogeneous and can be inherited as autosomal recessive
(50%–60%), autosomal dominant (30%–40%), or X-linked
(5%–15%).4 At present, 32 genetic loci have been impli-
cated in nonsyndromic autosomal-recessive RP (arRP)
(RetNet), most of which account for a few percent of RP
cases each. In five of the 32 previously reported arRP loci
(RP22, RP28, RP29, RP32, RP54), the causative gene is as
yet unknown. Two unrelated Indian arRP families were
linked to the RP28 locus on chromosome 2p14-p15.5,6
Recently, one of the genes in the linked interval, MDH1
(MIM *154200), was considered as a good candidate for
RP because of its role in the Krebs cycle, but it was found
to be negative for mutations via ultra high-throughput
sequencing analysis in these two RP28-linked families.7
Homozygosity mapping using high-density SNP micro-
arrays in consanguineous as well as nonconsanguineous
families is currently the most efficient tool for identifying
novel arRP genes.8–11 The Israeli and Palestinian popula-
tions that we serve are an efficient resource for the identi-
fication of disease-causing genes with the use of this
approach because of the relatively high level of consan-
guinity, large number of siblings per family, and presence
of subpopulations isolated over hundreds of years (The
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382 The American Journal of Human Genetics 87, 382–391, SeptembIn the present study, we used homozygosity mapping to
identify the cause of disease in families from Israel and the
Palestinian territories with arRP. Patients were of various
origins, including North African Jews, Ashkenazi Jews,
Syrian Jews, and Arab Muslims. The tenets of the Declara-
tion of Helsinki were followed, and informed consent was
obtained from all patients who participated in this study,
prior to donation of a blood sample. DNA was extracted
with the FlexiGene DNA Kit (QIAGEN) from the index
patient as well as from other affected and unaffected family
members. Whole-genome SNP analysis was performed
with the use of Affymetrix 250K microarrays. The criterion
for hybridization quality was set to p < 0.05, and a region
of homozygosity was determined by a minimal number of
100 consecutive homozygous markers. A relatively large
number of patients with arRP, mainly from consanguin-
eous families, had large homozygous regions on chromo-
some 2p. In 14 patients who belong to nine unrelated
families of North African Jewish origin, we identified the
most common haplotype (haplotype A; Figure 1A). In
addition, four patients from two Syrian Jewish families
shared a less common haplotype, haplotype B (Figure 1A).
The two haplotypes share a homozygous region of ~4 Mb
(60.67–64.51 Mb) that overlaps with the RP28 locus
reported in the two families of Indian origin.5,6 The shared
homozygous region contains 22 annotated genes (Fig-
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Figure 1. Autozygosity Mapping Results, Chromosomal Region, Gene Structure, and Mutations Identified in FAM161A
(A) The chromosomal region harboring the homozygous haplotypes at chromosome 2 (upper panel). Rulers are based on the February
2009 USCS Genome Browser build (hg19). The homozygous regions in the two previously reported RP28 Indian families are depicted as
black (homozygous regions) or gray (cosegregating heterozygous regions) bars. The lower set of horizontal bars represents the homozy-
gous region in our set of patients, as identified by whole-genome SNP analysis, depicted for each of the studied families. The family
origin, family number, and number of analyzed patients per family (in parentheses) are shown on the left. Each of the three core haplo-
types (A, B, C) is color-coded, with flanking homozygous regions marked by various colors indicating a deviation from the common
haplotype. The region flanked by SNPmarkers rs13034649 and ra2555418 covering ~4 Mb between 60.67 and 64.51 Mb was considered
the shared homozygous region. A smaller homozygous region that was identified in family MOL0696 was not used to define the shared
homozygous region because of its relatively small size (~1.8 Mb; 60.67–62.44 Mb).
(B) The genes located within the shared homozygous region are ordered on the basis of their genomic location, with an arrow indicating
gene orientation. Twelve of the 22 genes were screened for mutations and marked in bold. The FAM161A gene is highlighted in blue.
(C) Intron-exon structure of FAM161A and location of the null mutations. All seven exons are coding exons. Exon 2 contains an in-frame
ATG codon that might be used for initiation of translation. Exon 4 is alternatively spliced (see Figure 3 for more details).
(D) FAM161A mutations identified in patients with arRP. The chromatograms of a wild-type and a homozygous mutant individual are
depicted for each of the three mutations. The nucleotide change is shown below the chromatogram, and the amino acid is shown below
the second base of each codon. An arrow indicates the mutation location.
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Table 1. RP Families with FAM161A Mutations
Family
No. of Affected
Individuals
Level of
Consanguinitya Origin
Size and Range (Mb)
of Homozygous Region
Mutation in FAM161A
(Effect on Protein)
MOL0053 4 none Libyan Jew na p. Arg523X
p. Arg523X
MOL0100 2 none Moroccan Jew na p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0139 2 2:1 Moroccan Jew 14.90
(52.91–67.81)
p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0195 3 none Ashkenazi Jew (M)b,
Tunisian Jew (P)b
na p.Thr452SerfsX3 (M)b
p. Arg523X (P)b
MOL0276 3 3:3 Syrian Jew 14.01
(52.32–66.33)
p. Arg523X
p. Arg523X
MOL0284 1 none Ashkenazi Jew na p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0286 1 none Moroccan Jew na p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0303 1 none Bulgarian Jew na p.Thr452SerfsX3
p. Arg523X
MOL0352 1 none Libyan Jew na p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0446 1 none Libyan and
Moroccan Jew
na p.Thr452SerfsX3
p. Arg523X
MOL0526 2 none Moroccan Jew 8.00
(59.24–67.24)
p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0570 1 none Moroccan Jew 11.61
(55.88–67.49)
p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0672 1 none Moroccan Jew na p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0696 2 none Moroccan Jew 1.77
(60.67–62.44)
p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0740 2 none Moroccan Jew 6.80
(60.72–67.52)
p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0766 4 2:3 Moroccan Jew 13.53
(53.71–67.24)
p.Thr452SerfsX3
p.Thr452SerfsX3
MOL0777 2 2:2 Arab Muslim 52.82
(34.47–87.29)
p. Arg596X
p. Arg596X
MOL0784 2 2:2 Syrian Jew 27.13
(52.85–79.98)
p. Arg523X
p. Arg523X
MOL0786 1 none Moroccan Jew 5.93
(59.18–65.11)
p.Thr452SerfsX3
p.Thr452SerfsX3
TB21 4 2:1 Moroccan Jew 19.07
(49.26–68.33)
p.Thr452SerfsX3
p.Thr452SerfsX3
The table includes only families in which mutations were found on both alleles. Excluded from the table are two patients who were heterozygous for either the
c.1355_6delCA or the c.1567C>T mutation with no identifiable mutation on the counter allele. na, not analyzed.
a Level of consanguinity is measured by the number of generations separating the spouse from the common ancestor (e.g., 2:2 designates first cousins, 2:1
designates marriage between an uncle and his niece).
b M, maternal; P, paternal.retina. Using the Primer3 software,15 we designed primers
flanking all coding exons and exon-intron boundaries
of 12 genes (B3GNT2 [MIM *605581], CCT4 [MIM
*605142], COMMD1 [MIM *607238], C2ORF86, EHBP1
[MIM *609922], FAM161A, MDH1, OTX1 [MIM *600036],
PELI1, TMEM17, UGP2 [MIM *191760], VSP54) located
within the linked region that is overlapping with RP28
and performed sequence analysis in two patients repre-384 The American Journal of Human Genetics 87, 382–391, Septembsenting the two haplotypes. The analysis revealed two
homozygous null mutations in the FAM161A gene (Figures
1C and 1D, Figure S1, Table 1, Table S1): c.1355_6delCA
(p.Thr452SerfsX3) in patient MOL0766 V:2 (haplotype A)
and c.1567C>T (p.Arg523X) in patient MOL0276 II:2
(haplotype B). Sequence analysis of FAM161A in 12
additional patients with a homozygous region on chro-
mosome 2p revealed one patient, MOL0777 II:2 (from aer 10, 2010
consanguineous Arab Muslim family; Figure S1), with a
large homozygous haplotype (haplotype C; Figure 1A)
covering > 50 Mb, who was homozygous for a null muta-
tion in exon 5, c.1786C>T (p.Arg596X) (Figures 1C and
1D, Table 1). The three mutations that we identified are
expected to produce an abnormal transcript that is likely
to be recognized by the nonsense-mediated mRNA decay
system, resulting in the absence of FAM161A protein.
Less likely, the mutations might produce an abnormal
protein lacking a considerable portion of the normal
protein. In any case, these mutations cause loss of function
in a haplosufficiency mechanism.
To assess the frequency of the identified FAM161Amuta-
tions in the Israeli and Palestinian populations, we
screened a set of 206 index patients with inherited retinal
degeneration (mainly with arRP) for the three null muta-
tions by restriction analysis (Table S2) or by sequencing
of the corresponding exons on the basis of the patient’s
origin. This analysis revealed patients from 12 additional
families who were homozygous for the c.1355_6delCA
mutation and patients from two families with a homozy-
gous c.1567C>T mutation (Table 1 and Figure S1). In
addition, we identified patients from three families who
were compound heterozygous for c.1355_6delCA and
c.1567C>T (Table 1 and Figure S1). On the basis of haplo-
type data, these two mutations (c.1355_6delCA and
c.1567C>T) are founder mutations in the Israeli Jewish
population. Whereas such founder mutations in this pop-
ulation are usually restricted to a specific ethnic group (e.g.,
the USH3A [MIM *606397] p.N48K mutation in Ashkenazi
Jews, or the CERKL [MIM *608381] c.238þ1G>Amutation
among patients of Jewish Yemenite origin),16,17 it is inter-
esting to note that both FAM161A mutations were identi-
fied in three different ethnic groups (Table 1). Although
the c.1355_6delCA mutation was identified mainly in
families of North African Jewish origin, an Ashkenazi
Jewish origin was reported in two of the families and
a Bulgarian Jewish origin in one family. The c.1567C>T
mutation was identified in two Syrian Jewish families,
three North African Jewish families, and one family of
Bulgarian Jewish origin. The occurrence of a mutation in
different Jewish subpopulations, from different diasporas,
may indicate a relatively ancient origin of these mutations.
To assess the carrier frequency of each identified mutation,
we screened ethnically matched healthy controls for
each of the mutations. The p.Thr452SerfsX3 mutation
was identified heterozygously in four out of 127 controls
of North African Jewish ancestry (an estimated carrier
frequency of 1:32), and the mutation was not identified
in 108 Ashkenazi Jewish controls. The p.Arg523X muta-
tion was not identified in 108 North African Jewish
controls, and the p.Arg596X mutation was not identified
in 105 Arab Muslim controls.
In total, FAM161A mutations were identified in 20 (out
of 172; 11.6%) arRP families (including 41 patients) in
our cohort, and they perfectly cosegregated with the
disease (Table 1 and Figure S1). Until now, founder muta-The Americantions in two arRP genes were found to be a relatively
frequent cause of disease in the Israeli population: EYS
(MIM *612424, responsible for 5.8% of cases)18 and CERKL
(responsible for 4.7%; D.S. and T.B.Y. unpublished data
and ref. 16). The data that we present here suggest that
FAM161Amutations are currently themost common cause
of RP in our set of patients, representing the Israeli and
Palestinian populations (Figure S2). Moreover, the location
of FAM161A within the RP28 locus might indicate a more
general involvement of this gene as the cause of arRP in
other populations as well. Screening FAM161A in other
populations will indicate what percentage of arRP is caused
by this gene worldwide. Although the first nonsyndromic
retinal degeneration gene was identified about 20 years
ago,19 it is interesting to note that some of the newly iden-
tified genes, mainly CEP290 (MIM *610142) and EYS, also
account for a relatively large proportion of cases.18,20–22
Aiming to clinically characterize patients with FAM161A
mutations, we performed a full ophthalmologic examina-
tion, full-field electroretinography (ERG), optical coher-
ence tomography (OCT), autofluorescence (AF), Gold-
mann visual fields, and color vision testing as previously
described.23 Clinical evaluation of 28 patients showed
a spectrum of findings (Table S3, Figure 2). The majority
of patients were myopic, visual acuity ranged from no light
perception to 1.0, and mild lens opacities were observed
in many patients (Table S3). Fundus findings were rela-
tively mild and often intermingled with myopic changes.
Pallor of the optic disc and attenuation of retinal blood
vessels were almost always present, but bone-spicule-like
pigmentation was observed to only a limited degree in
most patients (perhaps related to the coexistent myopia)
(Figures 2A–2K). OCT imaging showed marked thinning
of the outer nuclear layer with relative preservation under
the fovea itself (Figures 2L and 2M). Full-field ERG
responses were extinguished in most patients (Table S3).
A comparison of cone flicker ERG responses in arRP
patients (Figure S3) with FAM161A mutations, EYS muta-
tions, or other genetic causes revealed significantly lower
amplitudes in the FAM161A (mean of 4.7 mV) and EYS
(0.7 mV) groups compared to patients with arRP of other
causes (17.8 mV). Impaired night vision and constriction
of visual fields showed a wide spectrum of severity (Fig-
ure S4). In summary, similar to patients with mutations
in other retinal genes,10,16,17,24,25 patients with FAM161A
mutations show a variable retinal phenotype that may be
due to modifier genes and/or environmental factors.
The FAM161A gene contains seven coding exons along
a genomic region of ~30 Kb. An analysis of FAM161A
transcripts available at NCBI revealed a number of
variants, two of which have an intact open reading
frame (ORF) (Figure 3A): a more common transcript in
which exon 4 is skipped (FAM161A-001 corresponding to
ENST00000405894 at Ensemble) with an ORF of 1983 bp
(a total of seven clones, including one from the human
retina) and a less common transcript (a total of two clones,
none from the human retina) that includes all codingJournal of Human Genetics 87, 382–391, September 10, 2010 385
Figure 2. The Spectrum of Fundus Findings among Different Families with Mutations in FAM161A
(A–I) Imaging of three pairs of siblings from families with the p.Thr452SerfsX3 mutation, showing different severity of funduscopic
changes: bone-spicule-like pigmentation was observed to only a limited degree in most patients (A, C, D, F as compared to H, I), but
many patients showed grayish spots extending from the arcades to the periphery. These correlated with spots of hypofluorescence
on AF imaging (B, E, G). In addition, a ring of hyperfluoresence around the fovea could be observed in many cases (B, E, G).
(J and K). Color fundus mosaic (J) and AF imaging of the macular area (K) in a patient with the R523X mutation.
(L and M) OCT imaging shows marked thinning of the outer nuclear layer, with relative preservation under the fovea itself. Fine
wrinkling of the retina can be seen in one of the scans (M), related to an epiretinal membrane.exons (FAM161A-005; ENST00000404929 with an ORF of
2151 bps). In both variants, the translation-initiation
codon might lie either within exon 1 or 109 codons down-
stream within exon 2 (FAM161A-201, ENSP00000397336;
Figure 3B). For verification of the expression of FAM161A-
005, RNA was isolated from the human retina with TRI
Reagent (Sigma-Aldrich) and cDNA was synthesized with
the Verso cDNA Kit (Thermo) in accordance with the
manufacturer’s protocol. PCR-specific primers (Table S1)
were designed with Primer3 and RT-PCR analysis was per-
formed, followed by sequence analysis of the PCR prod-
ucts. The analysis confirmed that both variants are tran-
scribed in the human retina, with FAM161A-001 being
the more common transcript (Figure 3A). In silico analysis
of FAM161A expression in human tissues (using expressed
sequence tags [ESTs] and serial analysis of gene expression
[SAGE] data) revealed the highest expression level in
the eye (10 out of 211,510 ESTs; 47 per million), whereas
lower expression levels were observed in a few other386 The American Journal of Human Genetics 87, 382–391, Septembtissues, including the brain, testis, liver, and lung. To better
characterize the distribution of FAM161A in human
tissues, we performed RT-PCR analysis using four primer
sets on cDNAs that were synthesized from RNA derived
from 20 human tissues (Clontech; catalog no. 636643,
lot no. 8101369A) and the human retina (Figures 3B and
3C). The human gene PGM1 (MIM *171900) was used as
an internal control. Three of the four primer sets showed
retina-specific expression (Figure 3C, rows 1, 2, and 4).
The primer set designed to exclusively amplify the tran-
script lacking exon 4 (FAM161A-001) showed a wider
distribution, including the cerebellum, fetal brain, testis,
and thyroid gland, which had cDNA amplifications that
were not as intense as the retinal cDNA amplification
(Figure 3C, row 3).
To determine the spatial and temporal expression
pattern of Fam161a, we performed in situ hybridization
(ISH) on sections of embryonic and postnatal mouse
eyes. ISH was performed with the use of a mouse cloneer 10, 2010
Figure 3. RT-PCR Analysis of FAM161A
(A) RT-PCR analysis of retinal cDNA (right
panel) revealed two FAM161A transcripts.
The major one, FAM161A_001, does not
contain exon 4, and the corresponding
chromatogram is depicted in the lower
sequencing panel. The less common
variant FAM161A_005 contains exon 4,
and the corresponding chromatogram is
depicted in the upper sequencing panel.
(B) The structure of the two transcripts and
the location of the primers used to amplify
the different mRNA regions that are
shown in (C). The red circle represents a
possible alternative initiation codon. The
black arrows above (forward) and below
(reverse) the transcript scheme represent
the four primer sets that were used to
analyze FAM161A transcripts in different
human tissues.
(C) RT-PCR analysis in 21 different human
tissues using the four sets of FAM161A
primers (panels 1–4) and a control gene,
PGM1 (panel 5). The primer names (corre-
sponding to B) and the PCR product
length are shown on the right.corresponding to the splice variant lacking exon 4
(FAM161A_001) and conducted as previously described.26
In brief, tissues were fixed for 24 hr in 4% paraformalde-
hyde, embedded in OCT medium, and sectioned at 16 mm.
Hybridization was conducted overnight at 65C with
digoxigenin-labeled probes (~5 mg/ml). The slides were
then treated with RNaseA, washed, blocked with 10%
normal goat serum (NGS), and incubated with sheep
anti-Digoxigenin Fab fragments conjugated to alkaline
phosphatase (1:250, Roche) in MABT (Maleic Acid Buffer,
0.1% Tween-20) with 20% NGS overnight at 4C, then
washed and incubated in BM Purple (Roche). Probes
used were Fam161a (Open Biosystem clone MMM1013-
7512149) and Crx.27 During embryogenesis (embryonic
day 12.5 [E12.5]–E16.5), low levels of Fam161a expression
were detected in the retinal progenitor cells (RPCs) of the
optic cup as well as in the posterior compartment of the
lens (Figures 4A–4C, antisense control in Figures 4M–4R).
Interestingly, Fam161a was not elevated in photoreceptor
precursors, identified by the expression of the cone rod
homeobox gene, Crx (Figures 4G–4I). In the postnatal
retina, however, Fam161a expression was barely detected
at postnatal day 1 (P1) but was elevated at P5 in the post-
migratory Crxþ photoreceptor precursors at the apicalThe American Journal of Human Genetside of the outer nuclear layer (ONL;
Figures 4D, 4E, 4J, and 4K). At P10,
when all retinal cell types and
layers have been generated, Crx was
detected in the photoreceptor layer
and in the inner nuclear layer (Fig-
ure 4L),28 whereas the expression
of Fam161a was confined to the
photoreceptor layer (Figure 4F). Therestricted expression of the mouse ortholog to the ONL
postnatally is supported by SAGE and in situ hybridization
data of a previous report.29 In addition, Fam161a is
expressed by RPCs during embryogenesis, but this expres-
sion in the progenitors is downregulated close to birth. In
mice, photoreceptor precursors are generated throughout
embryogenesis, with a peak around birth. The differentia-
tion of these precursors is completed only after birth,
when the outer segment is formed and genes involved in
phototransduction are expressed.29 The gradual accumula-
tion of Fam161a in the photoreceptor layer in mice after
birth seems to parallel the temporal pattern of expression
of other genes that characterize mature photoreceptors.29
Together, the expression pattern of Fam161a in the devel-
oping and postnatal retina implicates an involvement
during embryogenesis in the retinal progenitors, whereas
after birth its activity is restricted tomature photoreceptors.
It should be noted, however, that our human patients
with RP due to FAM161A mutations did not have any
ocular developmental abnormalities. It is therefore possible
that in human embryogenesis the paralogous protein,
FAM161B, has redundant activity with FAM161A. Interest-
ingly, a highpercentagedid developmyopia, andmanyhad
high myopia of over 6 diopters.ics 87, 382–391, September 10, 2010 387
Figure 4. Fam161a Is Expressed throughout the Optic Cup during Mouse Embryogenesis, and Its Expression Is Restricted to the
Photoreceptor Layer in the Postnatal Mouse Retina
Characterization of Fam161a and Crx expression by in situ hybridization during embryogenesis and postnatal development. Fam161a
expressionwas detected throughout the retinal neuroblastic layer (NBL) during embryonic stages (E12.5, E14.5, E16.5; A–C), whereasCrx
expression was restricted to the photoreceptor precursors (G–I). At postnatal stages, Fam161a expression became restricted to the photo-
receptors located at the outer rim of the outer neuroblastic layer (ONBL) (D–F). This expression was low at P1 (D) and increased at P5 (E).
At this stage, Crx was highly expressed in the ONBL and in some cells of the inner neuroblastic layer (INBL) (J–L). At P10, Fam161a was
detected in the ONL similar toCrx (F). Fam161a sense probe served as a negative control and failed to produce any nonspecific staining at
all stages tested (M–R). Abbreviations are as follows: OC, optic cup; NBL, neuroblastic layer; ONBL, outer neuroblastic layer; INBL, inner
neuroblastic layer; ONL, outer nuclear layer; INL, inner nuclear layer. Scale bar in (A) represents 100 mm.FAM161A encodes at least two protein isoforms com-
posed of 660 (due to skipping of exon 4) or 716 amino
acids. In addition, two translation-initiation sites might
be active, producing proteins that differ in the 109
N terminus amino acids. The encoded proteins contain
a single domain, Pfam UPF0564 (included in 15 proteins
and with an average length of 277 amino acids), of
unknown function. FAM161A has one paralog in the
human genome, FAM161B, which also contains the
UPF0564 domain. The conserved UPF0564 sequence is
also found in proteins of ‘‘lower’’ organisms and mainly in
the unicellular ciliate protozoa Paramecium tetraurelia.
Within UPF0564, FAM161A contains three conserved
a-helical coiled-coil structural motifs. These motifs can be
found inmanyproteins of all organisms andmightmediate
oligomerization or protein-protein interactions or are
perhaps important for protein structure and function.
Only one protein is currently known to interact with
FAM161A: a large-scale effort aimed at creating a human
protein-protein interaction network using the two-hybrid
system resulted in the identification of an interaction
between FAM161A and PPM1F,30 a ubiquitously expressed
protein acting as a Ser/Thr protein phosphatase. Compre-388 The American Journal of Human Genetics 87, 382–391, Septembhensive functional analyses are needed in order to gain
more information about the function of FAM161A in the
retina and the mechanism by which lack or dysfunction
of this protein causes retinal degeneration.
FAM161A orthologs can be found in mammals, chicken,
and zebrafish, but not in Drosophila. To gain insight into
protein regions that are preserved along evolution, we per-
formed a sliding window analysis comparing the human
protein sequence to selected orthologs (Figure 5A). Amino
acid sequences of FAM161A orthologs were extracted from
the Homologene database at NCBI. Amino acid sequences
were aligned with the ClustalW2 multiple alignment tool
at EBI. The sliding window analysis was performed, with
a 30 amino acid interval, between the human FAM161A
sequence and each representative ortholog. A very limited
percentage of amino acid identity was found in the
C terminus as well as in the N terminus, but two areas
showing a relatively high degree of preservation were iden-
tified: a region preserved in all sequences at amino acids
290–360, and a region conserved in mammalians ortho-
logs at amino acids 535–595. Both regions are located
within the UPF0564 domain. Notably, one of these regions
is encoded by the alternatively spliced exon 4, which iser 10, 2010
Figure 5. Evolutionary Analysis of FAM161A
(A) A scheme representing the human protein FAM161A is depicted at the top, with identified domains highlighted in yellow (UPF0564)
or dashed boxes (coiled-coil sequences). The exon boundaries are shown below. An amino acid sliding window (length of 30 amino
acids) comparing the human protein sequence to selected orthologs (macaca, dog, mouse, chicken, and zebrafish) is shown. x axis:
amino acid number; y axis: percentage of amino acid identity in a 30 amino acid window. The lower graph represents a summary of
the data in mammalian sequences (blue) versus all five sequences (red), with a cumulative sliding window analysis of data points
that are above the average percentage of amino acid identity for each studied sequence (macaca 95%, dog 72%, mouse 58%, chicken
39%, zebrafish 35%).
(B) A comparison of amino acid identity levels (comparing the human protein sequence to its ortholog in each of the six species) of all 25
known arRP proteins. The results obtained for FAM161A are marked in red. Note that there is no ortholog for FAM161A in Drosophila.
(C) A phylogenetic tree of FAM161A and FAM161B. Note the relatively long distances separating the orthologous FAM161A protein
sequences.present in only a low percentage of FAM161A transcripts.
The sliding window analysis indicated a relatively low level
of preservation of FAM161A along evolution. To compare
the level of amino acid preservation between FAM161A
and 25 other arRP proteins (CDHR1, CERKL, CNGA1,
CNGB1, CRB1, EYS, IDH3B, LRAT, MERTK, NR2E3, NRL,
PDE6A, PDE6B, PRCD, PROM1, RBP3, RGR, RHO, RLBP1,
RP1, RPE65, SAG, SPATA7, TULP1, USH2A), we calculated
the amino acid identity levels between each human
protein sequence and its orthologs in six species (Fig-
ure 5B). The analysis showed that FAM161A is one ofThe Americanthe least preserved proteins in five of the six available
comparisons. Phylogenetic analysis of the two FAM161
human paralogs (FAM161A and FAM161B) sequences
was performed with the use of the neighbor joining proce-
dure, with the chicken FAM161B sequence serving as an
outgroup. The analysis revealed that the two human paral-
ogs are distantly related, with a faster evolutionary rate
(indicated by the length of each branch) of FAM161A
(Figure 5C).
In conclusion, we report here that mutations in the
FAM161A gene, which is included in the RP28 region,Journal of Human Genetics 87, 382–391, September 10, 2010 389
can cause arRP. FAM161A is currently the most common
arRP gene in our Israeli cohort of patients. It is expressed
mainly in the retina, but the function of the encoded
protein is as yet unknown.Supplemental Data
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